Once-a-day Patch
All-day Relief
Licart® has unique patented drug patch technology for once-a-day treatment of acute pain due to minor strains, sprains, and contusions.
Targeted
Delivers medicine directly to where it hurts
Fast-Acting
Significant pain relief within 1-3 hours after first application¹
Long-Lasting
Delivers NSAID power for up to 24 hours²
Well-Tolerated
Low incidence of adverse events³
With the Licart Copay Savings Card, commercially insured patients can receive instant savings when purchasing Licart at any retail pharmacy.
Enrollees in government health insurance programs, including Medicare and Medicaid, are not eligible to use card. The parties reserve the right to rescind, revoke, or amend this offer without notice at any time.
Licart Direct is a convenient program based on a network of participating mail-order pharmacies that will deliver your prescription right to your doorstep. Licart Direct provides you with a low cash price, regardless of health insurance status.
What Makes Licart Different?
Licart is the only once-a-day topical nonsteroidal anti-inflammatory drug (NSAID) therapy available for acute pain due to minor strains, sprains, and contusions. Its patented next-generation patch technology goes to work fast for powerful pain relief that starts within 1-3 hours of application and can last all day with once-daily dosing.4
Licart delivers medicine directly to where it hurts and has a low incidence of adverse events.³
From IBSA, the makers of Flector® topical system.
Licart vs. Other NSAID Pain Relievers
| Licart® | Flector® (diclofenac epolamine) topical system |
Diclofenac 1% gel OTC | Diclofenac sodium topical solution 2.0% | Oral pain relievers†,†† | |
|---|---|---|---|---|---|
| 24-hour, once-a-day pain relief dosing |  |
||||
| Pain relief within 1-3 hours of medication | |
 |
|||
| Mess-free patch | |
|
|||
| Localization absorption of active ingredient | |
|
|
|
|
| Not habit-forming | |
|
|
|
|
| Prescription strength | |
|
|
|
† Nonprescription
†† Includes acetaminophen, ibuprofen, naproxen, etc.
Put Licart Where It Hurts
Licart is easy to use. Simply peel it from its adhesive backing, and apply it to where it hurts. Licart is mess-free, has no unpleasant odor, and will not stain clothes.
To learn more about using Licart, click here.
FOOT
BACK
NECK
SHOULDER
WRIST
ELBOW
ANKLE
KNEE
Take the Self-Assessment Questionnaire
Getting the right relief for your acute pain starts with knowing how to talk to your physician about your condition. Fill out this brief questionnaire to receive a copy of your responses that you can discuss with your doctor to determine if Licart is right for you.
INTERESTED IN TRYING LICART?
Let Us Help
INDICATIONS AND USAGE
LICART contains diclofenac epolamine, which is a nonsteroidal anti-inflammatory drug (NSAID), and is indicated for the topical treatment of acute pain due to minor strains, sprains, and contusions.
IMPORTANT SAFETY INFORMATION
WARNING: RISK OF SERIOUS CARDIOVASCULAR and GASTROINTESTINAL EVENTS
Cardiovascular Thrombotic Events
Nonsteroidal anti-inflammatory drugs (NSAIDs) cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. This risk may occur early in the treatment and may increase with duration of use.
LICART is contraindicated in the setting of coronary artery bypass graft (CABG) surgery.
Gastrointestinal Bleeding, Ulceration, and Perforation
NSAIDs cause an increased risk of serious gastrointestinal (GI) adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients and patients with a prior history of peptic ulcer disease and/or GI bleeding are at greater risk for serious GI events.
CONTRAINDICATIONS
LICART is contraindicated in the following patients:
Known hypersensitivity to diclofenac or any components of the drug product.
History of asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs.
In the setting of CABG surgery.
For use on non-intact or damaged skin.
WARNINGS AND PRECAUTIONS
Hepatotoxicity: Inform patients of warning signs and symptoms of hepatotoxicity. Discontinue if abnormal liver tests persist or worsen or if clinical signs and symptoms of liver disease develop.
Hypertension: Patients taking some antihypertensive medications may have impaired response to these therapies when taking NSAIDs. Monitor blood pressure.
Heart Failure and Edema: Avoid use of LICART in patients with severe heart failure unless benefits are expected to outweigh risk of worsening heart failure.
Renal Toxicity: Monitor renal function in patients with renal or hepatic impairment, heart failure, dehydration, or hypovolemia. Avoid use of LICART in patients with advanced renal disease unless benefits are expected to outweigh risk of worsening renal function.
Anaphylactic Reactions: Seek emergency help if an anaphylactic reaction occurs.
Exacerbation of Asthma Related to Aspirin Sensitivity: LICART is contraindicated in patients with aspirin-sensitive asthma. Monitor patients with preexisting asthma (without aspirin sensitivity).
Serious Skin Reactions: Discontinue LICART at first appearance of skin rash or other signs of hypersensitivity.
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Discontinue and evaluate clinically.
Fetal Toxicity: Limit use of NSAIDs, including LICART, between about 20 to 30 weeks in pregnancy due to the risk of oligohydramnios/fetal renal dysfunction.
Avoid use of NSAIDs in women at about 30 weeks gestation and later in pregnancy due to the risks of oligohydramnios/fetal renal dysfunction and premature closure of the fetal ductus arteriosus.
Hematologic Toxicity: Monitor hemoglobin or hematocrit in patients with any signs or symptoms of anemia.
ADVERSE REACTIONS
Most common adverse reactions for LICART are application site pruritus and other application site reactions. To report SUSPECTED ADVERSE REACTIONS, contact IBSA Pharma Inc. at: 1-800-587-3513 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
For Full Prescribing Information, visit licart.com/wp-content/uploads/2023/10/Licart-Full-Prescribing-Information_2024.pdf.